Submit your solution for clinician well-being to the 2021 Health Tech Venture Challenge by JUN 4.

Stories

Stay up to date on all healthcare news from MATTER, Chicago's leading incubator and accelerator.

matter news

BCBSIL and MATTER announce $30,000 Health Equity Innovation Challenge

October 5, 2018

Blue Cross and Blue Shield of Illinois is collaborating with MATTER to source innovative solutions for advancing health equity.

Submit your solution for a chance to win up to $15,000 and an opportunity to pilot your solution with Blue Cross and Blue Shield of Illinois.

What is health equity? Every person deserves an opportunity to be as healthy as possible. Health equity means reducing and, u…

Read more

matter news

MATTER & Kellogg launch new course to help students learn the business of healthcare entrepreneurship

September 26, 2018

As a business, healthcare is weird.

In other industries, if you produce a product that solves a problem, someone will buy it. Of course, you have to play with all the things that you learn about in business school, such as pricing, promotion and product refinements. And it’s never a sure thing: Someone may not be willing to pay enough for it. You might not be able to get your message out. Your…

Read more

matter news

MATTER partners with Novo Nordisk to fuel entrepreneurial innovation

September 24, 2018

The partners unveil an innovation challenge for technology startups to foster meaningful collaborations to improve diabetes care.

Chicago, IL, September 25, 2018 — MATTER, the premier healthcare incubator and innovation hub, today announced a partnership with Novo Nordisk, a global healthcare company with 95 years of innovation and leadership in diabetes. Through this challenge, MATTER and Nov…

Read more

matter news

MATTER announces programs focused on innovation in the life sciences

September 14, 2018

Chicago’s life sciences ecosystem is taking off: In the first half of this year, AveXis sold for $8.7 billion, the largest acquisition of a Chicago-area biotechnology company to date. Iterum Therapeutics, Xeris Pharmaceuticals and Aptinyx all went public, as did Exicure (whose CEO, David Giljohann, will be at MATTER in October for Tales from the Trenches). Between 2013 and 2017, 44% of funding …

Read more

matter news

MATTER and Consulate General of Canada collaborate to help Canadian life science entrepreneurs enter U.S. market

June 11, 2018

Bringing a new healthcare product to market is no easy task. But bringing a new healthcare product to market in another country with a different health system, regulatory environment and business landscape can be an even more daunting challenge.

To reduce the friction of entering the U.S. healthcare market, MATTER and the Consulate General of Canada work together on a mentorship program to sup…

Read more